Chapter 4: Biological Basis for Understanding Psychopharmacology
Intracranial Regulation and Principles of Neurobiology
Intracranial Regulation (ICR): This concept encompasses the normal and abnormal processes of intracranial function. Effective ICR depends on a consistent blood supply to deliver oxygen and nutrients, primarily utilizing carbohydrates as the main fuel source for the brain.
Goal of Psychiatric-Mental Health Nursing: The fundamental aims are to understand the neurobiology of psychiatric disorders, manage symptoms using psychotropic medications, and reduce the risk of patient relapse.
Brain Plasticity: Although the basic architecture of the brain is genetically programmed, "plasticity" allows for adaptation and change throughout life. This process involves the shrinking and thickening of gray matter and the forging or pruning of neuronal connections. These connections are significantly influenced by mental illness and the administration of psychotropic medications.
Functions of the Brain (Box ):
Monitoring changes in the external world.
Monitoring the composition of body fluids.
Regulating skeletal muscle contractions.
Regulating internal organs.
Initiating and regulating basic drives: hunger, thirst, sex, and aggressive self-protection.
Mediating conscious sensation.
Storing and retrieving memories.
Regulating mood (affect) and emotions.
Performing intellectual functions and thinking.
Regulating the sleep cycle.
Producing and interpreting language.
Processing visual and auditory data.
Major Brain Structures
Cerebrum (Cerebral Cortex): Often called the "higher brain," it is responsible for cognitive skills, self-awareness, and executive functions. It consists of four primary lobes:
Frontal Lobe: Responsible for conscious movement, problem-solving, speech production, goal selection, and social judgment. The Prefrontal Cortex (PFC) is the most anterior part, moderating social behaviors and personality.
Parietal Lobe: Involved in tactile sensation, spatial awareness, proprioception, reading, and mathematics.
Occipital Lobe: Primarily responsible for vision, visual processing, visual association, and visual memory.
Temporal Lobe: responsible for hearing, language reception, and comprehension; connects with the limbic system to allow emotional expression.
Brainstem: Regulates basic life functions such as heart rate, breathing, and sleep. It consists of the midbrain, pons, and medulla oblongata.
Reticular Activating System (RAS): Projections from the brainstem that control levels of consciousness and sedation. Many psychiatric drugs alter these signals, impacting wakefulness.
Cerebellum: Coordinates motor control, balance, and cognitive processing. Dysfunctions or decreases in size are associated with schizophrenia, explaining issues with coordination and poor cognitive performance (negative symptoms). Alcohol and benzodiazepines can impair cerebellar function, leading to ataxia and blurred vision.
Limbic System (The "Emotional Brain"): Deep gray matter structures including the hippocampus, amygdala, and basal ganglia.
Hippocampus: Interacts with the PFC to create new memories. Chronic stress can cause hippocampal shrinkage, contributing to depression.
Amygdala: Processes fear and anxiety. Hyperactivity is common in trauma and paranoia; hypoactivity may predict response to antidepressants.
Basal Ganglia: Plays a major role in motor responses via the extrapyramidal motor system, relying on dopamine. First-generation antipsychotics can cause changes here, leading to involuntary motor symptoms.
Thalamus: Filters sensory information before it reaches the cerebral cortex. Disrupted filtering is linked to schizophrenia.
Hypothalamus: Maintains homeostasis (temperature, BP, perspiration, libido, hunger, thirst, circadian rhythms). It directs the anterior pituitary via neurohormones like Corticotropin-Releasing Hormone (CRH). Dopamine in the hypothalamus inhibits prolactin; blocking this can lead to hyperprolactinemia.
Neuroimaging and Brain Visualization
Structural Imaging (Anatomical Detail):
Computed Tomography (CT): Serial X-ray "slices" used to detect lesions, abrasions, infarcts, or aneurysms; shows gray-matter reduction or ventricle abnormalities in schizophrenia.
Magnetic Resonance Imaging (MRI): Uses magnetic fields and radio waves for high-resolution cross-sectional images; used to exclude neurological disorders.
Functional Imaging (Brain Activity):
Positron Emission Tomography (PET): Uses injected radioactive substances to visualize oxygen utilization, glucose metabolism, and neurotransmitter-receptor interaction. Shows decreased frontal lobe metabolism in schizophrenia and increased metabolism in OCD.
Single-Photon Emission Computed Tomography (SPECT): Similar to PET but use -radiation (photons); less costly with lower resolution.
Functional MRI (fMRI): Relies on magnetic properties of blood flow to see activity as it occurs. The Striatal Connectivity Index (SCI) may eventually predict medication response.
Cellular Composition and Neurotransmission
Neurons: Over interconnected nerve cells that initiate signals via electrical impulses. Conduction involves the inward movement of sodium () ions and outward movement of potassium () ions.
Synaptic Transmission: Electrical signals are converted to chemical signals (neurotransmitters) at the synapse. Transmitters are released from the presynaptic axon terminal, diffuse across the synapse, and attach to postsynaptic receptors.
Neurotransmitter Destruction Mechanisms:
Enzymatic Destruction: Enzymes like acetylcholinesterase or monoamine oxidase (MAO) break down the transmitter at the postsynaptic membrane or within the presynaptic cell.
Reuptake: The presynaptic cell takes back the transmitter to be reused or destroyed later. This is a primary target for many psychotropic drugs.
Major Neurotransmitters (Table ):
Dopamine (DA): Affects fine muscle movement, integration of emotions/thought, and decision making. Increased in psychosis and mania; decreased in Parkinson’s and depression.
Norepinephrine (NE): Affects mood, attention, arousal, and "fight-or-flight." Increased in mania/anxiety; decreased in depression.
Serotonin (): Affects sleep, hunger, pain, and aggression. Decreased in depression.
Histamine: Related to alertness and inflammatory response. Blockage causes sedation and weight gain.
-aminobutyric acid (GABA): Major inhibitory neurotransmitter. Reduces anxiety and excitation. Increase leads to reduced anxiety; decrease leads to mania and psychosis.
Glutamate: Major excitatory neurotransmitter. NMDA receptors play a role in learning; high levels cause neurotoxicity and neurodegeneration.
Acetylcholine (ACh): Regulates mood, learning, and memory. Stimulates the parasympathetic nervous system. Decreased in Alzheimer’s disease.
Psychotropic Drug Classes and Interactions
Pharmacokinetic Interactions: Occur when one drug alters the absorption, distribution, metabolism (often via Cytochrome P450 / CYP450 enzymes), or elimination of another.
Pharmacodynamic Interactions: Occur when drugs act at the same or interrelated receptor sites, causing synergistic or antagonistic effects (e.g., combining benzodiazepines and antihistamines).
Antidepressant Drugs:
Selective Serotonin Reuptake Inhibitors (SSRIs): Prevent reuptake of serotonin (e.g., fluoxetine, sertraline, citalopram). Side effects include anxiety, insomnia, sexual dysfunction, and GI distress.
Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs): Block reuptake of serotonin and NE (e.g., venlafaxine, duloxetine).
Norepinephrine-Dopamine Reuptake Inhibitors (NDRIs): Bupropion is used for depression and smoking cessation; it does not act on the serotonin system.
Tricyclic Antidepressants (TCAs): Block NE and serotonin reuptake. Known as "dirty drugs" due to many side effects (sedation, weight gain, orthostatic hypotension, and cardiotoxicity in overdose).
Monoamine Oxidase Inhibitors (MAOIs): Increase monoamines by inhibiting the MAO enzyme. Require a low-tyramine diet (avoid aged/fermented foods) to prevent Hypertensive Crisis. Dietary restrictions must continue for weeks after stopping the drug.
Antianxiety (Anxiolytic) Drugs:
Benzodiazepines: Potentiate GABA. Risk of tolerance, withdrawal, and abuse. Potential for fatal respiratory depression when combined with other CNS depressants like alcohol or opioids.
Buspirone (BuSpar): Reduces anxiety without strong sedative effects or addiction potential; high affinity for receptors.
Mood Stabilizers:
Lithium: Affects cellular signaling; has a low therapeutic index. Requires monitoring of blood levels, kidney function, and thyroid function. Toxicity risk increases with sodium depletion.
Anticonvulsants: Valproate (risk of hepatotoxicity and pancreatitis), Lamotrigine (risk of Stevens-Johnson Syndrome), and Carbamazepine (risk of aplastic anemia and agranulocytosis).
Antipsychotic Drugs:
First-Generation (Typical): D2 receptor antagonists. Effectively treat positive symptoms but cause Extrapyramidal Symptoms (EPS) (dystonia, akathisia, parkinsonism), Tardive Dyskinesia (TD), and Neuroleptic Malignant Syndrome (NMS).
Second-Generation (Atypical): Serotonin-dopamine antagonists. Lower risk of EPS. Significant metabolic side effects: weight gain, hyperglycemia, and lipid abnormalities.
Clozapine: Requires weekly blood draws for the first months to monitor Absolute Neutrophil Count (ANC) due to risk of agranulocytosis.
Ziprasidone: Must be taken with food (at least calories) for absorption; can prolong the QTc interval.
Specialized Concepts and Discussion
Psychoneuroimmunology (PNI): Research into the relationship between the immune system, nervous system, behavior, and health. Chronic inflammation and cytokines can reduce hippocampal neurogenesis and lead to mood changes.
Cross-Cultural Psychopharmacology: Explores ethnic variations in drug response based on genetics and cultural beliefs.
Questions & Discussion:
Case Scenario (Trazodone): For a patient prescribed trazodone for insomnia who is not depressed: "In low doses, trazodone helps relieve insomnia. Higher doses are needed for antidepressant effects."
Case Scenario (Cerebellum Abscess): Priority nursing diagnosis is "Risk for falls related to loss of balance and equilibrium."
Case Scenario (Problem Solving): A patient with schizophrenia on long-term haloperidol might have the most difficulty with decision making due to negative symptoms and drug effects.
Nursing Intervention for Risperidone: Always assess sitting, standing, and lying blood pressure daily due to risk of orthostatic hypotension.